Charles Schwab’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,003,074
| Closed | -$14.7M | – | 3465 |
|
|
2025
Q3 | $14.7M | Sell |
1,003,074
-60,898
| -6% | -$621K | ﹤0.01% | 1912 |
|
|
2025
Q2 | $10.4M | Buy |
1,063,972
+78,201
| +8% | +$648K | ﹤0.01% | 1992 |
|
|
2025
Q1 | $7.17M | Buy |
985,771
+174,945
| +22% | +$1.53M | ﹤0.01% | 2116 |
|
|
2024
Q4 | $6.34M | Buy |
810,826
+89,776
| +12% | +$739K | ﹤0.01% | 2231 |
|
|
2024
Q3 | $5.34M | Buy |
721,050
+53,932
| +8% | +$453K | ﹤0.01% | 2344 |
|
|
2024
Q2 | $5.34M | Buy |
667,118
+37,885
| +6% | +$338K | ﹤0.01% | 2336 |
|
|
2024
Q1 | $7.32M | Buy |
629,233
+129,880
| +26% | +$1.44M | ﹤0.01% | 2145 |
|
|
2023
Q4 | $5.58M | Buy |
499,353
+10,349
| +2% | +$95.1K | ﹤0.01% | 2264 |
|
|
2023
Q3 | $7.55M | Buy |
489,004
+322,339
| +193% | +$5.41M | ﹤0.01% | 2067 |
|
|
2023
Q2 | $3.16M | Buy |
166,665
+145,639
| +693% | +$2.56M | ﹤0.01% | 2412 |
|
|
2023
Q1 | $320K | Buy |
21,026
+5,724
| +37% | +$74.6K | ﹤0.01% | 3075 |
|
|
2022
Q4 | $195K | Hold |
15,302
| – | – | ﹤0.01% | 3190 |
|
|
2022
Q3 | $89K | Buy |
+15,302
| New | +$67.2K | ﹤0.01% | 3233 |
|
|
2022
Q2 | – | Sell |
-20,663
| Closed | -$78K | – | 3569 |
|
|
2022
Q1 | $78K | Sell |
20,663
-4,146
| -17% | -$26.7K | ﹤0.01% | 3460 |
|
|
2021
Q4 | $325K | Hold |
24,809
| – | – | ﹤0.01% | 3269 |
|
|
2021
Q3 | $487K | Sell |
24,809
-38,037
| -61% | -$695K | ﹤0.01% | 3156 |
|
|
2021
Q2 | $1.18M | Buy |
62,846
+3,466
| +6% | +$77.4K | ﹤0.01% | 2870 |
|
|
2021
Q1 | $1.41M | Buy |
59,380
+4,629
| +8% | +$107K | ﹤0.01% | 2746 |
|
|
2020
Q4 | $1.33M | Buy |
54,751
+14,703
| +37% | +$376K | ﹤0.01% | 2697 |
|
|
2020
Q3 | $1.03M | Buy |
40,048
+8,762
| +28% | +$278K | ﹤0.01% | 2668 |
|
|
2020
Q2 | $624K | Buy |
31,286
+2,481
| +9% | +$60.3K | ﹤0.01% | 2754 |
|
|
2020
Q1 | $728K | Buy |
28,805
+469
| +2% | +$13.7K | ﹤0.01% | 2575 |
|
|
2019
Q4 | $745K | Buy |
+28,336
| New | +$789K | ﹤0.01% | 2686 |
|
Other funds holding ETNB
Charles Schwab's ETNB Position: Q4 2025 in Review
Charles Schwab sold out of 89bio (ETNB) in Q4 2025, closing a stake of 1,003,074 shares — an estimated $14.7M sold.
Charles Schwab first reported a position in ETNB in Q4 2019 and held it in 23 quarters. The position peaked at $14.7M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Charles Schwab reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Charles Schwab sold 1,003,074 89bio shares in Q4 2025, an estimated $14.7M.
- Charles Schwab first reported a position in 89bio in Q4 2019 and held it in 23 quarters.
- Charles Schwab's 89bio position peaked at $14.7M in Q3 2025.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Charles Schwab's 13F filing for Q4 2025, filed 13 Feb 2026.